Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipodystrophy, Familial Partial”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Not applicableStudy completedNCT07090629
What this trial is testing

The Benefits of the Measureof Epicardial Adipose Tissue During Coronary Calcium Assessment of the Refine Cardiovascular Risk Assessment at Reunion Island.

Who this might be right for
High CholesterolLipodystrophy, Familial PartialDiabetes
Centre Hospitalier Universitaire de la Réunion 126
Not applicableWithdrawnNCT04056000
What this trial is testing

Lipodystrophy and Fat Metabolism During Exercise

Who this might be right for
HealthyLipodystrophy, Familial Partial
University of Exeter
Large-scale testing (Phase 3)Ended earlyNCT02527343
What this trial is testing

The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial Lipodystrophy

Who this might be right for
Familial Partial Lipodystrophy
Akcea Therapeutics 40
Testing effectiveness (Phase 2)Study completedNCT03514420
What this trial is testing

Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL)

Who this might be right for
Familial Partial Lipodystrophy
Akcea Therapeutics 4
Not applicableStudy completedNCT05424913
What this trial is testing

Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan's Lipodystrophy

Who this might be right for
LipodystrophyDunnigan Syndrome
Centre Hospitalier Universitaire de la Réunion 150
Not applicableStudy completedNCT02858830
What this trial is testing

Familial Partial Lipodystrophy Study

Who this might be right for
Lipodystrophy, Familial Partial
Mayo Clinic 12
Not applicableLooking for participantsNCT03553420
What this trial is testing

Registry for Patients With Lipodystrophy

Who this might be right for
Lipodystrophy AcquiredLipodystrophy Congenital
University of Ulm 5,000
Not applicableStudy completedNCT02577952
What this trial is testing

Lipodystrophy Connect Patient Registry

Who this might be right for
Lipodystrophy
PatientCrossroads 257
Large-scale testing (Phase 3)Looking for participantsNCT06679270
What this trial is testing

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

Who this might be right for
Familial Partial Lipodystrophy
Chiesi Farmaceutici S.p.A. 24
Testing effectiveness (Phase 2)Study completedNCT02430077
What this trial is testing

Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients

Who this might be right for
Familial Partial Lipodystrophy
Abhimanyu Garg 10
Not applicableNot Yet RecruitingNCT07799012
What this trial is testing

Sexual Quality of Life in Female Patients With Lipodystrophy Syndromes or Turner's Syndrome: a Case-control Study

Who this might be right for
Lipodystrophy Congenital GeneralizedLipodystrophy, Familial PartialTurner Syndrome
Assistance Publique - Hôpitaux de Paris 1,416
Not applicableLooking for participantsNCT05996536
What this trial is testing

Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)

Who this might be right for
Lipodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 14
Not applicableStudy completedNCT05789251
What this trial is testing

Assess the Possibility of Diagnosing Diabetes and Rediabetes Following Oral Induced Hyperglycemia in Patients With Dunnigan's Partial Familial Lipodystrophy by Replacing 75 g of Glucose With a Standardized Carbohydrate Breakfast and Continuous Interstitial Monitoring Glucose)

Who this might be right for
Lipodystrophy
Centre Hospitalier Universitaire de la Réunion 54
Not applicableStudy completedNCT04845165
What this trial is testing

Study of Cortisol Metabolism in Familial Partial Lipodystrophy Type 2

Who this might be right for
Familial Partial Lipodystrophy Type 2
University Hospital, Lille 25
Large-scale testing (Phase 3)Looking for participantsNCT07220785
What this trial is testing

Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy

Who this might be right for
Generalized Lipodystrophy
Regeneron Pharmaceuticals 28
Not applicableLooking for participantsNCT07412028
What this trial is testing

Identification of Women With Severe Insulin Resistant Syndromes of Genetic Origin Among Patients With "Classic" Polycystic Ovary Syndrome (PCOS)

Who this might be right for
Polycystic Ovary SyndromeFamilial Partial LipodystrophyLMNA (LaMin Nuclear A) Related Disorders
Assistance Publique - Hôpitaux de Paris 81
Not applicableStudy completedNCT06107439
What this trial is testing

Impact of Lipodystrophy on the Inflammatory State of Non-diabetic Dunnigan Reunion Island Subjects

Who this might be right for
LipodystrophyDunnigan Syndrome
Centre Hospitalier Universitaire de la Réunion 64
Not applicableLooking for participantsNCT03900286
What this trial is testing

Low Energy Diet and Familial Partial Lipodystrophy

Who this might be right for
LipodystrophyDiabetesDiet Modification
Cambridge University Hospitals NHS Foundation Trust 20
Testing effectiveness (Phase 2)Study completedNCT02654977
What this trial is testing

CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy

Who this might be right for
Familial Partial LipodystrophyNonalcoholic SteatohepatitisNAFLD
University of Michigan 11
Testing effectiveness (Phase 2)Ended earlyNCT05088460
What this trial is testing

Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD)

Who this might be right for
Familial Partial LipodystrophyMetabolic Abnormalities
Regeneron Pharmaceuticals 20
Next Page